Editas Medicine Inc (EDIT)
2.37
-0.04
(-1.66%)
USD |
NASDAQ |
Nov 21, 16:00
2.38
+0.01
(+0.42%)
After-Hours: 20:00
Editas Medicine Price to Book Value: 1.114 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.114 |
| November 20, 2024 | 1.133 |
| November 19, 2024 | 1.166 |
| November 18, 2024 | 1.184 |
| November 15, 2024 | 1.250 |
| November 14, 2024 | 1.302 |
| November 13, 2024 | 1.391 |
| November 12, 2024 | 1.443 |
| November 11, 2024 | 1.551 |
| November 08, 2024 | 1.466 |
| November 07, 2024 | 1.490 |
| November 06, 2024 | 1.542 |
| November 05, 2024 | 1.466 |
| November 04, 2024 | 1.354 |
| November 01, 2024 | 1.368 |
| October 31, 2024 | 1.363 |
| October 30, 2024 | 1.419 |
| October 29, 2024 | 1.462 |
| October 28, 2024 | 1.532 |
| October 25, 2024 | 1.494 |
| October 24, 2024 | 1.494 |
| October 23, 2024 | 1.508 |
| October 22, 2024 | 1.546 |
| October 21, 2024 | 1.767 |
| October 18, 2024 | 1.579 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.556 |
| October 16, 2024 | 1.621 |
| October 15, 2024 | 1.579 |
| October 14, 2024 | 1.523 |
| October 11, 2024 | 1.499 |
| October 10, 2024 | 1.391 |
| October 09, 2024 | 1.466 |
| October 08, 2024 | 1.490 |
| October 07, 2024 | 1.508 |
| October 04, 2024 | 1.588 |
| October 03, 2024 | 1.504 |
| October 02, 2024 | 1.513 |
| October 01, 2024 | 1.537 |
| September 30, 2024 | 1.602 |
| September 27, 2024 | 1.237 |
| September 26, 2024 | 1.241 |
| September 25, 2024 | 1.205 |
| September 24, 2024 | 1.255 |
| September 23, 2024 | 1.301 |
| September 20, 2024 | 1.340 |
| September 19, 2024 | 1.39 |
| September 18, 2024 | 1.379 |
| September 17, 2024 | 1.372 |
| September 16, 2024 | 1.362 |
| September 13, 2024 | 1.404 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.114
Minimum
Nov 21 2024
14.40
Maximum
Jan 08 2021
3.497
Average
2.287
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 8.090 |
| EyePoint Pharmaceuticals Inc | 2.605 |
| Cassava Sciences Inc | 9.291 |
| Adverum Biotechnologies Inc | 0.83 |
| Regenxbio Inc | 1.509 |
Price to Book Value Related Metrics
| PS Ratio | 3.152 |
| Price | 2.37 |
| Earnings Yield | -108.0% |
| Market Cap | 195.64M |